tiprankstipranks
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market
Want to see AU:BGT full AI Analyst Report?

Bio-Gene Technology Ltd. (BGT) Financial Statements

10 Followers

Bio-Gene Technology Ltd. Financial Overview

Bio-Gene Technology Ltd.'s market cap is currently AU$7.45M. The company's EPS TTM is AU$-0.0071; its P/E ratio is -2.27; Bio-Gene Technology Ltd. is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 0.00AU$ 18.32KAU$ 149.23KAU$ 445.73K
Gross ProfitAU$ -42.00KAU$ -245.78KAU$ -301.45KAU$ -164.04KAU$ 178.59K
Operating IncomeAU$ -3.41MAU$ -3.07MAU$ -3.06MAU$ -3.63MAU$ -3.41M
EBITDAAU$ -3.36MAU$ -2.58MAU$ -2.97MAU$ -3.14MAU$ -2.92M
Net IncomeAU$ -2.33MAU$ -2.58MAU$ -2.41MAU$ -3.10MAU$ -2.91M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 1.94MAU$ 1.14MAU$ 2.21MAU$ 2.99MAU$ 6.34M
Total AssetsAU$ 2.61MAU$ 2.15MAU$ 3.16MAU$ 3.84MAU$ 7.30M
Total DebtAU$ 0.00AU$ 51.21KAU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -1.94MAU$ -1.14MAU$ -2.21MAU$ -2.99MAU$ -6.34M
Total LiabilitiesAU$ 519.76KAU$ 522.98KAU$ 368.45KAU$ 613.88KAU$ 1.03M
Stockholders' EquityAU$ 2.09MAU$ 1.63MAU$ 2.79MAU$ 3.22MAU$ 6.27M
Cash Flow
Free Cash FlowAU$ 0.00AU$ -2.54MAU$ -2.76MAU$ -3.28MAU$ 36.67K
Operating Cash FlowAU$ -1.94MAU$ -2.54MAU$ -2.75MAU$ -3.28MAU$ 43.52K
Investing Cash FlowAU$ 0.00AU$ 0.00AU$ -5.70KAU$ 0.00AU$ -6.84K
Financing Cash FlowAU$ 2.74MAU$ 1.47MAU$ 1.98MAU$ -75.00KAU$ 4.41M
Currency in AUD

Bio-Gene Technology Ltd. Earnings and Revenue History

Bio-Gene Technology Ltd. Debt to Assets

Bio-Gene Technology Ltd. Cash Flow

Bio-Gene Technology Ltd. Forecast EPS vs Actual EPS